RECORDATI INDUSTRIA CHIMICA E FARMACEUTI (OTCMKTS:RCDTF) Shorts Decreased By 2.04%

RECORDATI INDUSTRIA CHIMICA E FARMACEUTI (OTCMKTS:RCDTF) had a decrease of its shorted shares by 2.04%. In January was issued RCDTF’s total 350,500 shorted shares by FINRA. The 357,800 previous shares are down with 2.04%.

$37.37 was the last price.It’s since January 11, 2018 and is 0.00% down. The stock the S&P500 by 0.00%.

Recordati S.p.A. engages in the research, development, manufacture, marketing, and sale of pharmaceuticals.The firm is worth $. The firm offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, musculo-skeletal disorders and analgesia, pregnancy test, urology, OTC/non-prescription pharmaceuticals, allergy, antiinfectives, central nervous system, endocrinology, gastrointestinal, gynecology, obstetrics, nutrition and related areas, immunosuppressants, pediatrics, pneumology, hematology, oncology, respiratory, and generics.Last it reported negative earnings. Further, the firm produces pharmaceutical chemicals, such as active pharmaceutical ingredients and intermediates.

More recent RECORDATI (OTCMKTS:RCDTF) news were published by Seekingalpha.com, Seekingalpha.com and Seekingalpha.com. The first one has “Recordati: A Somehow Boring But Interesting Pharmaceutical Company – Seeking Alpha” as a title and was published on May 24, 2018. The next is “Recordati Industria Chimica e Farmaceutica S.p.A. 2018 Q2 – Results – Earnings Call Slides – Seeking Alpha” on July 26, 2018. And last was published on June 07, 2018, called “Recordati (RCDTF) Presents At Jefferies 2018 Global Healthcare Conference – Slideshow – Seeking Alpha”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.